Flying completely under the radar of the various crises that have come to define 2020, an interesting story is playing out in India. This story shines a light on the increasingly globalized nature of medical research and on the dark practice of using poor people in third-world nations as guinea pigs in that research.

In early May, the US Centers for Disease Creation and Propaganda (CDC) announced a $3.6 million grant to “further strengthen and support the Indian government’s efforts to increase laboratory capacity for SARS-COV-2 testing.” But just days later, it was reported that the grant may be delayed because the CDC was placed on a “watch list” by the Indian Ministry of Home Affairs last December.

Wait, what? The Indian government placed the CDC on a “watch list” last year? Why?

So why is India watch-listing the CDC? And does this mean that the practice of using developing countries as laboratories for medical research is finally coming to an end? Get the details in this week’s edition of The Corbett Report Subscriber.

To access the full newsletter and to support this website, please become a member today.

For free access to this editorial, please CLICK HERE.